Treatment of Binge Eating Disorder

被引:0
作者
Crow S. [1 ]
机构
[1] University of Minnesota Medical Center, 2312 S 6th St f256, Minneapolis, 55454, MN
关键词
Anti-depressants; Behavioral weight loss; Binge eating; Binge eating disorder; Cognitive behavioral therapy; Eating disorder; Obesity; Weight loss;
D O I
10.1007/s40501-014-0023-4
中图分类号
学科分类号
摘要
Binge eating disorder is a common eating disorder that recently has received increasing attention. Goals in treating binge eating disorder typically include controlling binge eating and diminishing excess body weight. A variety of treatment approaches have been used, including diet/lifestyle modification, psychotherapy, and pharmacologic treatment. Diet and lifestyle interventions are somewhat effective in diminishing the binge eating behavior and lead to modest weight loss, but the weight effects are limited and not typically lasting. A number of psychotherapies have been shown to be beneficial, mostly for stopping binge eating, and tend to show little impact on weight loss. Numerous pharmacologic interventions have been developed, with the focus on antidepressants (used for their anti-binge eating effects) and weight loss drugs. Both have been shown to be helpful but again, for antidepressants, bringing about lasting weight loss appears to be difficult. The most effective approach to treating binge eating disorder (if available) is likely psychotherapy combined with medication management as indicated. © 2014, Springer International Publishing AG.
引用
收藏
页码:307 / 314
页数:7
相关论文
共 22 条
[11]  
McElroy S.L., Casuto L.S., Nelson E.B., Et al., Placebo-controlled trial of sertraline in the treatment of binge eating disorder, Am J Psychiatr, 157, 6, pp. 1004-1006, (2000)
[12]  
Claudino A.M., de Oliveira I.R., Appolinario J.C., Et al., Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder, J Clin Psychiatry, 68, 9, pp. 1324-1332, (2007)
[13]  
McElroy S.L., Arnold L.M., Shapira N.A., Et al., Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial, Am J Psychiatr, 160, 2, pp. 255-261, (2003)
[14]  
McElroy S.L., Hudson J.I., Capece J.A., Et al., Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study, Biol Psychiatry, 61, 9, pp. 1039-1048, (2007)
[15]  
McElroy S.L., Kotwal R., Guerdjikova A.I., Et al., Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial, J Clin Psychiatry, 67, 12, pp. 1897-1906, (2006)
[16]  
Guerdjikova A.I., McElroy S.L., Welge J.A., Et al., Lamotrigine in the treatment of binge-eating disorder with obesity: a randomized, placebo-controlled monotherapy trial, Int Clin Psychopharmacol, 24, 3, pp. 150-158, (2009)
[17]  
McElroy S.L., Guerdjikova A.I., Winstanley E.L., Et al., Acamprosate in the treatment of binge eating disorder: a placebo-controlled trial, Int J Eat Disord, 44, 1, pp. 81-90, (2011)
[18]  
Golay A., Laurent-Jaccard A., Habicht F., Et al., Effect of orlistat in obese patients with binge eating disorder, Obes Res, 13, 10, pp. 1701-1708, (2005)
[19]  
Grilo C.M., Masheb R.M., Salant S.L., Cognitive behavioral therapy guided self-help and orlistat for the treatment of binge eating disorder: a randomized, double-blind, placebo-controlled trial, Biol Psychiatry, 57, pp. 1193-1201, (2005)
[20]  
Guerdjikova A.I., McElroy S.L., Kotwal R., Et al., High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial, Hum Psychopharmacol, 23, 1, pp. 1-11, (2008)